Related Experiment Video
Updated: May 23, 2026

Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
Published on: January 17, 2014
Genomic characterization of invasive Streptococcus pneumoniae isolates from a southern Taiwan medical centre,
Poyen Liu1,2, Anne-Kathryn Venero3, Theresa Tran3
1Institute of Medicine, Chung Shan Medical University, Taichung, Taiwan, ROC.
Insights
Invasive pneumococcal disease (IPD) now affects older adults and those with cancer more often. Targeted prevention is needed for these vulnerable groups, especially regarding antibiotic resistance in pneumococcal serotypes.
Area of Science:
- Microbiology
- Epidemiology
- Genomics
Background:
- Pneumococcal conjugate vaccines (PCVs) reduced invasive pneumococcal disease (IPD) in children.
- IPD cases and serotype distribution have shifted to older adults and immunocompromised individuals.
- Data on pneumococcal serotype and antibiotic resistance in the Asia-Pacific post-PCV and post-COVID-19 pandemic are scarce.
Purpose of the Study:
- To analyze patient demographics, pneumococcal serotypes, and antibiotic resistance profiles in IPD cases.
- To investigate these profiles using whole-genome sequencing in southern Taiwan.
- To inform targeted prevention strategies for vulnerable populations.
Main Methods:
- Whole-genome sequencing (WGS) of 61 invasive pneumococcal disease isolates.
- Analysis of patient characteristics, serotype distribution, and antimicrobial resistance patterns.
- Phylogenetic analysis to identify emerging lineages.
Main Results:
- IPD predominantly affected patients aged 65+ (47.5%) and those with malignancy (34.3%).
- Serotypes covered by 13-valent PCV (PCV13) accounted for 52.5% of isolates.
- Overall penicillin non-susceptibility was 26.2%, rising to 43.8% for PCV13 serotypes.
Conclusions:
- Older adults and individuals with comorbidities, especially malignancy, are key populations for IPD.
- Emergence of multidrug-resistant strains, like serotype 34/ST9395, is a concern.
- Enhanced surveillance and targeted interventions are crucial for controlling IPD in vulnerable groups.
Abstract:
Since the introduction of pneumococcal conjugate vaccines, the incidence of invasive pneumococcal disease (IPD) among children has decreased significantly. The distribution of IPD cases has shifted towards other vulnerable populations, including older adults and individuals with pre-existing medical conditions. Alongside this shift, there has also been a concurrent change in pneumococcal serotype distribution. Studies on the distribution of pneumococcal serotypes and antibiotic resistance patterns in the post-pneumococcal conjugate vaccine era, particularly following the coronavirus disease 2019 (COVID-19) pandemic, remain limited in the Asia-Pacific region. This study aims to investigate patient characteristics, pneumococcal serotype and antibiotic resistance profiles predicted by whole-genome sequencing among IPD patients in a public medical centre in southern Taiwan. A total of 61 IPD isolates were collected between 2015 and 2023. Serotype and antibiotic resistance were determined using whole-genome sequencing. The results showed that 47.5% of cases were in patients aged 65 years and older and 34.3% of cases involved patients with comorbid malignancy. The serotypes included in the 13-valent pneumococcal conjugate vaccine (PCV13) comprised 52.5% of the isolates. Overall, 26.2% of isolates were non-susceptible to penicillin (non-meningitis breakpoint). For the PCV13 serotypes, the non-susceptible rate to penicillin (non-meningitis breakpoint) was 43.8%. Phylogenetic analysis suggested recent emergence of a multi-drug resistant serotype34/ST9395 lineage. These findings suggest that the older adult population and those with pre-existing medical conditions, particularly malignancy, could benefit from targeted prevention efforts.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Atypical Pneumonia
Pneumonia I: Introduction
Mechanism of Antibiotic Resistance in MRSA
Single Nucleotide Polymorphisms-SNPs
Modern Molecular Taxonomy
